1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Recurrent Acute Leukemia of Ambiguous Lineage: new trials by email Literature Review of Recurrent Acute Leukemia of Ambiguous Lineage trials Research Report on Recurrent Acute Leukemia of Ambiguous Lineage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia Biospecimen Collection, Bone Marrow Aspiration, Calaspargase Pegol - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia | Phase 2 | Active not recruiting | Children's Oncology Group | 78 | 2024-01-08 | 2026-08-25 |
Leukemia, Biphenotypic, Acute (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Asparaginase (1) · Cytarabine (1) · Hydrocortisone (1) · Methotrexate (1) · Methylprednisolone (1) · Prednisolone (1) · Prednisone (1) · Specimen Handling (1) · Spinal Puncture (1) · Vincristine (1) · calaspargase pegol (1) · deltacortene (1) · fludarabine phosphate (1) · hydrocortisone hemisuccinate (1) · merphos (1)
Canada (1) · United States (1)
Kelly E Faulk (1)
U10CA180886 (1)